Description
erbitox lv 4,Indication in combination with encorafenib for metastatic colorectal cancer (CRC) with a BRAF V600E mutation (as determine by FDA-approved test) after prior therapy. Initial: 400 mg/m2 IV x 1.
Beige and white GG Supreme canvas
ERBITOX LV 4
Gold-toned hardware
Erbitox LV 4
Double G
Inside: 2 open pocket
Erbitux Stage 4 — Cancer Survivors Network
Chain top handle with 7″ drop
Top zip closure
ERBITUX
9.1″W x 2.9″H x 2.2″D
Weight: 0.6lbs approximately
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS